Charlotte Leduc

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

Nicolas Delanoy, Jean‐Marie Michot, Thibault Comont et al. · The Lancet Haematology · 2018 · 292 citations

Pharmacy, Hematology, Immunology +16

Grey wolf genomic history reveals a dual ancestry of dogs

Anders Bergström, David W. G. Stanton, Ulrike H. Taron et al. · Nature · 2022 · 189 citations · Full text

Life Sciences, Biology, Genetics +17

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program

Charlotte Leduc, J.P. Merlio, Benjamin Besse et al. · Annals of Oncology · 2017 · 93 citations · Full text

Medicine, Molecular Genetics, Oncology +10

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma

Julien Adam, Émilie Louvet, Tony Sourisseau et al. · ESMO Open · 2018 · 91 citations · Full text

Medicine, Immunology, Oncology +16

Activity of EGFR Tyrosine Kinase Inhibitors in NSCLC With Refractory Leptomeningeal Metastases

Ronan Flippot, Pamela Biondani, Édouard Auclin et al. · Journal of Thoracic Oncology · 2019 · 37 citations · Full text

Medicine, Oncology, Pharmacology +14